当前位置: 首页 > 期刊 > 《中国医学创新》 > 202025
编号:13809813
丹参酮ⅡA联合尼可地尔对冠心病左主干病变患者的临床疗效分析(2)
http://www.100md.com 2020年9月5日 《中国医学创新》 202025
     3 months after treatment, LVEF and 6-min walking distance of the two groups were significantly improved compared with those of before treatment, and the LVEF of the experimental group was more significantly improved than that of the control group, the differences were statistically significant (P<0.05). Conclusion: Tanshinone ⅡA Sodium Sulfonate Injection combined with Nicorandil can effectively relieve symptoms ......
上一页1 2 3 4下一页

您现在查看是摘要页,全文长 3750 字符